Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal trial, which showed that CABOMETYX® (cabozantinib) provided significant improvements in ...
Here’s the context: we know that Tr*mp has made a big deal about ending his years-long friendship with Epstein in 2004. In Tr*mp’s version of events, that was the year he found out about “the girls,” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results